RecallDepth
Class II Terminated

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
July 21, 2022
Posted
August 10, 2022
Recall Number
D-1303-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
5677 bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Dissolution Specifications: below specification limits for dissolution.

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot 1411596A, Exp 09/22

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls